purdue pharma lp formerly purdue frederick company american privately held pharmaceutical company founded john purdue gray sold arthur mortimer raymond sackler owned principally sackler family company manufactured pain medicines hydromorphone fentanyl codeine hydrocodone oxycodone also known brand name oxycontin sacklers developed aggressive marketing tactics persuading doctors prescribe oxycontin particular doctors enticed free trips painmanagement seminars effectively allexpensespaid vacations paid speaking engagements sales drugs soared number people dying nearly people died drug overdoses united states prescription illicit opioids responsible sackler family described worst drug dealers evil family series lawsuits followed purdue paid one largest fines ever levied pharmaceutical firm misleading public addictive drug oxycontin compared pain response lawsuits company shifted focus abusedeterrent formulations continued market sell opioids late continued involved lawsuits around opioid epidemic united purdue filed chapter bankruptcy protection september new york october reported purdue reached settlement potentially worth billion admitting knowingly intentionally conspired agreed others aid abet doctors dispensing medication without legitimate medical purpose members sackler family additionally pay million company state attorneys general protested march united states house representatives introduced bill would stop bankruptcy judge case granting members sackler family legal immunity bankruptcy house judicial committee referred subcommittee antitrust commercial administrative law october bill lapsed end congress january september purdue pharma announced would rebrand knoa august purdue pharma remains chapter bankruptcy pending department justice appeal united states supreme court us circuit court appeals ruling bankruptcy proceedings may companys downfall subject hulu miniseries dopesick netflix series painkiller several documentaries books company became purdue pharma founded medical doctors john purdue gray george frederick bingham new york city purdue frederick company made tonic compound made sherry sixty years later company sold three medical doctors brothers arthur raymond mortimer sackler relocated business yonkers new york brothers held onethird share company arthurs share passed brothers death mortimer died followed raymond sacklers company opened additional offices new jersey connecticut headquarters located stamford connecticut modern company purdue pharma lp incorporated focused pain management medication calling pioneer developing medications reducing pain principal cause human suffering extendedrelease formulation morphine ms contin released oxycontin released curtis wright employee food drug approved use dosage around time oxycontins release american pain society introduced pain fifth vital sign campaign veterans health administration adopted campaign national pain management september companys website said people month company announced would acquire vm pharma process gaining access worldwide development commercial rights allosteric selective tropomyosin receptor kinase inhibitor program ie phase ii candidate deal could generated million vm oxycontin became blockbuster drug oxycontin brought billion revenue purdue cumulative revenues increased billion billion companys profits go sackler family trusts according article new yorker purdue pharma owned one americas richest families collective net worth thirteen billion many us states allege family worth forbes magazine listed sacklers one wealthiest families us noted sacklers contributed money museums universities cultural institutions around however purdue website makes little mention anyone sackler family ownership allen frances former chair psychiatry duke university school medicine said name pushed forward epitome good works fruits capitalist system comes earned fortune expense millions people addicted shocking gotten away companys branches include purdue pharma lp purdue frederick company purdue pharmaceutical products lp purdue products lp manufacturing takes place three sites purdue pharmaceuticals lp plant located wilson north carolina pf laboratories inc totowa new jersey rhodes technologies lp coventry rhode island purdue pharma lp also research labs cranbury new jersey oxycontin currently distributed throughout us canada mexico distribution takes place pf laboratories totowa new jersey rhodes pharmaceuticals sister company established rhode island company one largest producers offpatent generic opioids sister companies purdue also controlled descendants sackler brothers napp pharmaceuticals united kingdom selling opioids globally new drugs developed company names adlon therapeutics imbrium based building parent company downtown stamford share richard sackler son raymond sackler started work company named president became cochairman board richard oversaw research department developed oxycontin managed sales marketing craig landau appointed ceo june joined purdue pharma lp chief medical officer vice president rd innovation clinical medical affairs appointed president ceo purdue pharma eight members sackler family listed active former members board steve miller became chairman july early sacklers departed purdue pharma board leaving board five purdue pharma manufactures pain medicines hydromorphone oxycodone fentanyl codeine hydrocodone makes drugs ms contin oxycontin ryzolt contin controlled drugrelease system developed commonly abused medications company produces ms contin oxycontin abused crushing chewing snorting injecting dissolved product ingestion methods create significant risk abuser result overdose death drugseeking tactics addicts undergo obtain medication include doctor shopping visiting number different physicians obtain additional prescriptions refusal follow appropriate examinations using pill mills prescriber practices lax controls along high potential abuse among people without prescriptions also risk physical dependency reduced reaction drug desensitization patients prescribed nevertheless strong analgesic drugs remain indispensable patients severe acute cancer first step marketing strategy seek approval sell oxycontin food drug administration purdue managed get approved even though longterm studies assessment addictive capabilities approval prescribe oxycontin moderate severe pain granted dr curtis wright iv medical review officer fda according purdue documents review conducted justice department wright met purdue pharma representatives hotel room near fda offices rockville maryland january february allowed company help draft medical officers review mor oxycontin fda included approving wording certain texts used oxycontins package insert wright resigned fda year later subsequently employed consultant purdue substantially higher salary information label approved fda contained text delayed absorption provided oxycontin tablets believed reduce abuse liability ambiguous text believed reduce abuse liability became key issue subsequent lawsuits purdue quoted felony conviction company criminal david kessler fda commissioner time later said approval oxycontin doubt mistake certainly one worst medical mistakes major oxycontin systematically marketed limited potential addiction abuse purdue trained sales representatives convey doctors risk addiction oxycontin less one related feature strategy purported low risk could prescribed effective treatment chronic pain virtually condition cancer nonmalignant pain market much larger market cancerrelated pain making total opioid market purdues promotion oxycontin treatment pain led nearly tenfold increase prescriptions less serious pain million purdue achieved marketing strategy richard sackler put place company aggressively pressed doctors prescribe oxycontin wooing free trips painmanagement seminars according study american journal public health physicians pharmacists nurses attended allexpensespaid symposia recruited trained purdues national speaker sales soared overdoses purdue claimed one dose oxycontin relieved pain hours twice long generic medications marketed smooth sustained pain control day night taken however patients found wore eight hours less investigation los angeles times reported many people oxycontins schedule adequately control pain resulting withdrawal symptoms including intense craving drug los angeles times quoted theodore j cicero neuropharmacologist washington university school medicine st louis said doesnt last hours patients suffer return underlying pain beginning stages acute withdrawal cicero said becomes powerful motivator people take drugs times suggested problem gives new insight many people become purdue well aware oxycontin provide pain relief hours even drug went market held fast claim relief part protect revenue oxycontins market dominance high hundreds dollars per duration instead prescribing small doses frequently doctors advised keep patients hour cycle prescribe stronger dose thereby exacerbating reports oxycontin abuse began surface start proactive abuse surveillance program called researched abused diversion addictionrelated surveillance radars sponsored purdue pharma lp pronounced oxycontin hydrocodone commonly abused pain drug enforcement administration found purdues aggressive methods much exacerbated oxycontins widespread new england journal medicine published study found percent seeking help heroin addiction began abusing pharmaceutical narcotics primarily drew direct line purdues marketing oxycontin subsequent heroin epidemic us according new york times based confidential justice department report revealed may purdue also aware reports pills crushed snorted stolen pharmacies doctors charged selling prescriptions hundred internal company memos included words street value crush october kirk ogrosky deputy chief fraud division us department justice wrote internal memorandum shows government prosecutors found evidence executives drugs giant purdue pharma may committed multiple crimes including wire fraud money laundering boost sales oxycontin document confirms settlement purdue government deceptive marketing claims fell far short prosecutors actually sought six months senators sheldon whitehouse maggie hassan requested justice department give copy memo stating purported include evidence purdue pharma executives may lied told congress knowledge extensive abuse diversion oxycontin made known memo recommends purdue executives michael friedman paul goldenheim howard udell charged felonies could sent lawsuits initiated purdue state local states across usa filed claims trillion purdue pharma bankruptcy connecticut attorney general richard blumenthal issued statement urging purdue take action regarding abuse oxycontin observed purdue seemed sincere little action taken beyond cosmetic symbolic purdue announced plans reformulate drug blumenthal noted would take time purdue pharma moral legal obligation take effective steps address addiction abuse even works reformulate west virginia attorney general sued purdue reimbursement excessive prescription costs paid state saying patients taking drug prescribed effects drug wore hours schedule state charged purdue deceptive marketing ruling trial judge wrote plaintiffs evidence shows purdue could tested safety efficacy oxycontin eight hours could amended label case never went trial purdue agreed settle paying state million equivalent approximately programs discourage drug abuse evidence remaining seal may company pleaded guilty misleading public oxycontins risk addiction agreed pay million equivalent approximately one largest pharmaceutical settlements us history companys president michael friedman top lawyer howard r udell former chief medical officer paul goldenheim pleaded guilty individuals misbranding charges criminal violation agreed pay total million friedman udell goldenheim agreed pay million million million respectively addition three top executives charged felony sentenced hours community service drug treatment october kentucky officials sued purdue widespread oxycontin abuse appalachia lawsuit filed kentucky thenattorney general greg stumbo pike county officials demanded millions eight years later december kentucky settled purdue january city everett washington sued purdue based increased costs city use oxycontin well purdue intervening noted odd patterns sale product per agreement suit noted allegations say purdue follow legal agreements track suspicious excess ordering potential black market usage suit says false clinics created unscrupulous doctors used homeless individuals patients purchase oxycontin sold citizens black market sale drug legal pharmacies based los angeles distributions points everett also said part experience city according suit intervention made purdue contact dea years despite knowing practice overuse sale product suit asks yet determined reimbursement related costs policing housing health care rehabilitation criminal justice system park recreations department well loss life compromised quality life citizens everett may six nevada north carolina north dakota tennessee lawsuits charging deceptive marketing practices adding previously filed lawsuits us states puerto january states suing purdue pharma massachusetts attorney general maura healey filed lawsuit purdue pharma also claimed eight members sackler family personally responsible deceptive sales practices fact micromanaged deceptive sales campaign response company said rush purdue started oxycontin savings card program patients receiving discounts first five prescriptions internal company data showed discounts led percent patients staying oxycontin longer days court filing massachusetts stated purdue determined opioid savings cards worked like teaser rate longterm highstakes march purdue pharma reached million settlement filed oklahoma claimed opioids contributed deaths thousands familys philanthropy characterized reputation laundering profits acquired selling response role purdue opioid crisis photographer nan goldin launched organization pain pressure museums cultural institutions divest sackler family may least institutions dropped sackler name including metropolitan museum art yale university usa national gallery london institutions stopped accepting donations sackler august purdue pharma sackler family negotiations settle claims payment settlement would include chapter filing purdue pharma would restructured public beneficiary trust sackler family would give ownership company addiction treatment drugs currently developed company would given public costfree profits purdue would henceforth go plaintiffs case top sackler family would contribute billion cash family would also sell mundipharma contribute another billion sales proceeds settlement however sackler family would remain billionaire family would criminally charged contributing opioid purdue filed bankruptcy white plains new york days reaching tentative however many states refused terms proposed settlement vowed pursue litigation recover additional money much alleged hidden offshore states seeking hold individual family members personally liable costs opioid epidemic regardless purdues bankruptcy contend sacklers knew litigants would pursuing purdues funds committed fraudulent september office new york attorney general accused sackler family hiding money wiring least billion company accounts personal accounts december audit alixpartners hired purdue guidance chapter restructuring said sacklers withdrew billion purdue company began receive legal october purdue agreed billion settlement includes billion criminal forfeiture billion criminal fine billion damages civil liability plead guilty three criminal charges become public benefit company trust required consider american public health sacklers permitted involved new sacklers sought controversial ruling judge robert drain grant immunity protect assets lawsuits linked opioid crisis sacklers seeking bankruptcylike protection court without actually filing personal bankruptcy number state attorneys general argued deal would force states suspend efforts investigate members family hold august us representatives carolyn maloney mark desaulnier introduced sackler act try prevent people filed bankruptcy released lawsuits brought states municipalities us government maloney claimed sackler family using loophole bankruptcy system protect billions dollars wealth accused department justice complicit devising settlement august proposed act passed september company approval billion us plan legally dissolve pharmaceutical manufacturer restructure public benefit corporation focused addressing opioid crisis repaying individuals families damaged products restructuring would financed settlement sackler family insurance payments ongoing business operations would eliminate familys exposure civil litigation settlement overturned december judge colleen mcmahon us district court southern district new york basis bankruptcy code permit judge release sacklers civil march us bankruptcy judge approved settlement involving eight states plus district columbia terms settlement agreement sacklers would required pay billion trust used pay claims opioid creditors including states victims addiction hospitals municipalities decision would shield sacklers personal civil liability potential criminal may us second circuit court appeals new york endorsed billion settlement sackler family giving ownership purdue profits sent fund prevent treat opioid ruling reversed lower court decision would shield sacklers opioidrelated lawsuits despite personally filing however august supreme court united states paused bankruptcy settlement agreed hear appeal made united states department justice legality settlement would shield sackler family civil lawsuits role opioid epidemic oral arguments case harrington v purdue pharma lp set december httpsenwikipediaorgwikipurduepharma